Lawyers for a French pharmaceutical group suspected in the deaths of at least 500 people argued Monday that a trial against their client should be halted as two separate cases should be rolled into one before the court can proceed.
The trial of Servier on charges of "aggravated deception" opened in Nanterre, west of Paris just as a similar case is being investigated in the French capital over the diabetes drug Mediator.
The company is accused of hiding that Mediator - also used for weight loss - contained an amphetamine called benfluorex, which was taken off the market in 2009 after being found to thicken heart valves.
Read more - French trial opens in diabetes-diet drug scandal - seattlepi.com
No comments:
Post a Comment